<- Back to digest

JBJS - 2026-10-09 - Journal Article

To Lengthen or Revise: Reevaluating Anterior Acetabular Overhang Thresholds in Iliopsoas Impingement After Total Hip Arthroplasty.

Clark DS, Kelly JJ, Yanamala SR, Helgeson EE, Trousdale RT, Levy BA, Taunton MJ, Hevesi M

retrospective cohortLOE IVn = 86 hips (83 patients)Mean 2.5 years (range 1–7.5 years)

Topics

arthroplasty
PMID: 42853909DOI: 10.2106/JBJS.26.00011View on PubMed ->

Key Takeaway

Arthroscopic iliopsoas fractional lengthening achieved equivalent outcomes regardless of acetabular overhang magnitude, with acetabular revision rates of 1.5% (<8 mm) vs. 5% (≥8 mm) that were not statistically different (p=0.387), challenging the 8-mm threshold that historically dictated cup revision.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This study asked whether the traditional 8-mm anterior acetabular overhang threshold should continue to guide the decision between acetabular revision and iliopsoas tenotomy/lengthening in post-THA iliopsoas impingement. Eighty-six hips undergoing arthroscopic IPFL were stratified into <8-mm (n=67) and ≥8-mm (n=19) overhang cohorts and compared on PROMs, reoperation, and revision rates. No significant differences were found in VAS pain, modified Harris Hip Score, SANE, Tegner, or satisfaction scores, and acetabular revision rates were low in both groups (1.5% vs. 5%, p=0.387).

Key Limitation

The ≥8-mm cohort (n=19) is too small to reliably detect differences in low-frequency outcomes such as acetabular revision, meaning the study cannot exclude a clinically important revision rate difference between groups.

Original Abstract

BACKGROUND

Iliopsoas impingement (IPI) is a known cause of persistent anterior hip pain following total hip arthroplasty (THA). Management of IPI has often relied on an 8-mm anterior acetabular overhang threshold to guide operative treatment, favoring acetabular revision for greater overhang and iliopsoas tenotomy for lesser overhang. These thresholds were initially established on the basis of the outcomes of open tenotomy, and now, with an improved understanding of IPI and the advent of arthroscopic iliopsoas fractional lengthening (IPFL), a review of the 8-mm threshold is warranted.

METHODS

A retrospective review was performed to identify patients who underwent arthroscopic IPFL following primary THA between 2017 and 2024, with a minimum follow-up of 1 year. Acetabular overhang was measured for all patients using cross-table lateral radiographs, and patients were stratified into <8-mm and ≥8-mm cohorts. Patient-reported outcome measures, reoperations, revisions, and complications were collected and analyzed on the basis of both the classic 8-mm threshold and continuous statistical methods.

RESULTS

We evaluated 86 hips undergoing IPFL. There were 83 patients (30 men and 53 women), with a mean age of 63.0 ± 11.2 years; with regard to race, 80 patients were White, 1 patient was Black or African American, and 2 patients listed other race or chose not to disclose. The acetabular overhang was <8 mm for 67 hips and ≥8 mm for 19 hips. The mean follow-up was 2.5 ± 1.6 years (range, 1 to 7.5 years). When comparing patients with <8-mm and ≥8-mm acetabular overhang, we observed no significant differences (p > 0.06) in the preoperative and postoperative visual analog scale (VAS) pain scores, modified Harris hip score, Single Assessment Numeric Evaluation (SANE) score, Tegner activity level, subjective groin pain improvement, subjective hip flexion strength improvement, and overall satisfaction. Reoperation (2.9% compared with 10.5%; p = 0.210) and acetabular revision rates (1.5% compared with 5%; p = 0.387) were not significantly different between the <8-mm and ≥8-mm overhang groups.

CONCLUSIONS

Arthroscopic IPFL provided satisfactory outcomes for patients with IPI, independent of the magnitude of acetabular overhang. IPFL should be considered for first-line surgical management of IPI refractory to nonoperative management, even in the setting of substantial acetabular overhang, given positive outcomes and low rates of subsequent acetabular revision.

LEVEL OF EVIDENCE

Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.